Categories: Breast Cancer Treatment Tags: Advisory, Avastin, Committee, From, Meeting, Provides, Roche, Update
At Democrats’ meeting; Public is invited to Wyman’s talk
At Democrats’ meeting; Public is invited to Wyman’s talk
Lt. Gov. Nancy Wyman will address the Democratic Town Committee on Thursday, June 16, at 7:30 p.m. in the town hall meeting room. The public is invited. Connecticut’s second in command will present an overview of the recent legislative session. A question and answer session will follow. Before being sworn in alongside Gov. Dannel Malloy in January 2011, Nancy Wyman served as state comptroller …
Read more on Redding Pilot
Categories: Breast Cancer Information Tags: Democrats’, invited, Meeting, Public, talk, Wyman’s
BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting
BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the “Electrochemotherapy 1st International Users’ Meeting”(Bologna, Italy, November 19-20, 2010).
Read more on News-Medical-Net
Categories: Breast Cancer Pain Tags: AMEP, BioAlliance, Clinical, Electrochemotherapy, Meeting, Melanoma, Phase, preclinical, presents, Results
Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting
Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting
Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA antagonists. These antagonists are based on the locked nucleic acid technology platform targets licensed from Santaris Pharma A/S.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Tumor Tags: 2010, Data, Enzon, EORTCNCIAACR, Meeting, presents
Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting
Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting
Incyte Corporation announced the presentation of final six-month clinical data from the dose ranging, placebo-controlled Phase IIa trial of its orally available janus kinase (JAK) inhibitor INCB28050 in patients with active rheumatoid arthritis (RA).
Read more on News-Medical-Net
Categories: Breast Cancer Pain Tags: ACR/ARHP, arthritis, Data, INCB28050, Incyte, Meeting, Phase, presents, rheumatoid, Trial
ArQule announces ARQ 197 Phase 2 clinical trial results at ESMO annual meeting
ArQule announces ARQ 197 Phase 2 clinical trial results at ESMO annual meeting
ArQule, Inc. today announced the presentation of final results from a Phase 2 clinical trial in non-small cell lung cancer (NSCLC) of ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, at the annual meeting of the European Society for Medical Oncology (ESMO).
Read more on News-Medical-Net
Categories: Metastatic Breast Cancer Tags: Announces, annual, ArQule, Clinical, ESMO, Meeting, Phase, Results, Trial
Myrexis to present MPI-0485520 preclinical data at Annual Scientific Meeting
Myrexis to present MPI-0485520 preclinical data at Annual Scientific Meeting
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: annual, Data, Meeting, MPI0485520, Myrexis, preclinical, present, Scientific
Meeting will address possible health risks associated with wireless connections
Meeting will address possible health risks associated with wireless connections
Parents alarmed about possible health risks associated with wireless connections in Bluewater and Simcoe area public schools have organized information meetings at the Thornbury library Wednesday at 4 and 7 p.m.[...]
Read more on Owen Sound Sun Times
Categories: Breast Cancer Radiation Tags: address, Associated, Connections, health, Meeting, possible, Risks, wireless
BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
RICHMOND, British Columbia — BioCurex Inc. today announced that the International Society of Oncology and Biomarkers Congress Scientific Committee has accepted BioCurex’s presentation on the RECAF blood test potential to monitor cancer recurrence and treatment.
Read more on GlobeNewswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Accepted, BioCurex, cancer, Data, international, Markers, Meeting, Monitoring, Presentation, Scientific
Genentech Provides Update From Avastin FDA Advisory Committee Meeting
Genentech Provides Update From Avastin FDA Advisory Committee Meeting
Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin’s U.S. label. The committee’s vote does …
Read more on Medical News Today